MIST
Milestone Pharmaceuticals Inc
0.8097$
-0.7%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -13.6% | +27.6% | -7.1% | -7.3% | -8.7% | -18.0% | -23.4% | +85.1% | +29.4% | +70.6% | -6.3% | |
| – | -13.9% | +28.7% | -7.0% | -7.3% | -8.7% | -18.2% | -23.7% | +87.7% | +29.1% | +71.8% | -6.2% | |
| – | +39.3% | -26.4% | +30.9% | -3.5% | +97.8% | +78.1% | -5.7% | +9.8% | +56.5% | -2.4% | +138.0% | |
| – | -12.9% | +35.6% | -7.0% | -8.2% | -8.8% | -19.7% | -22.4% | +90.2% | +28.3% | +73.9% | -7.4% | |
| – | +84.3% | -44.8% | +12.7% | -14.4% | +16.7% | -9.6% | -7.3% | -24.7% | +132.6% | +42.6% | -20.8% | |
| – | – | – | – | – | – | – | – | – | – | +181.8% | +158.6% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -0.3% | -4.1% | +2.1% | +2.5% | +6.2% | +9.1% | -4.2% | +3.2% | +6.8% | +119.6% | +3.6% | |
| – | -10.9% | -42.8% | +10.6% | +15.1% | +54.5% | +59.5% | -28.4% | +13.4% | +32.8% | +49.8% | +5.9% | |
| – | +3.0% | +1.6% | +2.2% | +2.6% | -1.9% | -5.1% | -5.0% | -6.2% | +34.0% | +1.9% | +1.7% | |
| – | +114.6% | -56.6% | -56.6% | +117.8% | +18.5% | +23.4% | +22.8% | +8.7% | +77.3% | +77.6% | -15.7% | |
| – | +1.8% | +1.8% | +1.8% | +1.8% | +1.8% | +1.8% | +1.8% | +1.8% | +1.8% | +1.8% | +1.7% | |
| – | -41.2% | +138.0% | -19.9% | -24.9% | -45.2% | -146.6% | – | – | +103.7% | -13.7% | -49.5% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -22.1% | +49.8% | +31.9% | +0.0% | -6.0% | +6.5% | +0.1% | +28.3% | -1.5% | +55.3% | +6.5% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.